Skip to main content
SpringerLink
Log in

Anthelmintics

A Comparative Review of Their Clinical Pharmacology

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Virtually all the important helminth infections in humans can be treated with one of 5 anthelmintics currently in use: albendazole, mebendazole, diethylcarbamazine, ivermectin and praziquantel. These drugs are vital not only for the treatment of individual infections, but also useful in controlling transmission of the more common infections. This article reviews briefly the pharmacology of these 5 drugs, and then discusses current issues in the use of anthelmintics in the treatment and/or control of soil-transmitted nematode infections, filariasis, onchocerciasis, schistosomiasis (and other trematode infections), neurocysticercosis and hydatidosis.

Mebendazole and albendazole are most effective against intestinal nematodes, but are contraindicated during the first trimester of pregnancy. The efficacy of prolonged therapy with these 2 drugs for treatment of larval cestode infections has not yet been established. Diethylcarbamazine is widely used to treat and control lymphatic filariasis, but adverse effects related to death of microfilariae or damage to adult worms may be marked. While ivermectin has been used in the treatment of patients with onchocerciasis, it is also undergoing investigation against lymphatic filariae. Praziquantel, used to treat schistosome infections, is also effective in other trematode infections and adult cestode infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lacey E. Mode of action of benzimidazoles. Parasitol Today 1990; 6(4): 107–12

    Google Scholar 

  2. Townsend LB, Wise DS. The synthesis and chemistry of certain anthelmintic benzimidazoles. Parasitol Today 1990; 6(4): 107–12

    PubMed  CAS  Google Scholar 

  3. Gottschall DW, Theodorides VJ, Wang R. The metabolism of benzimidazole anthelmintics. Parasitol Today 1990; 6(4): 115–24

    PubMed  CAS  Google Scholar 

  4. Albonico M, Smith PG, Hall A, et al. A randomized controlled trial comparing mebendazole and albendazole against Ascaris, Trichuris and hookworm infections. Trans R Soc Trop Med Hyg 1994; 88(5): 585–9

    PubMed  CAS  Google Scholar 

  5. Jongsuksuntigul P, Jeradit C, Pornpattanakul S, et al. A comparative study on the efficacy of albendazole and mebendazole in the treatment of ascariasis, hookworm infection and trichuriasis. Southeast Asian J Trop Med Public Health 1993; 24(4): 724–9

    PubMed  CAS  Google Scholar 

  6. Ismail MM, Premaratne UN, Suraweera MG. Comparative efficacy of single dose anthelmintics in relation to intensity of geohelminth infections. Ceylon Med J 1991; 36(4): 162–7

    PubMed  CAS  Google Scholar 

  7. Raccurt CP, Lambert MT, Bouloumie J, et al. Evaluation of the treatment of intestinal helminthiases with albendazole in Djohong (North Cameroon). Trop Med Parasitol 1990; 41(1): 46–8

    PubMed  CAS  Google Scholar 

  8. Sinniah B, Chew PI, Subramaniam K. A comparative trial of albendazole, mebendazole, pyrantel pamoate and oxantel pyrantel pamoate against soil-transmitted helminthiases in school children. Tropical Biomedicine 1990; 7(2): 129–34

    Google Scholar 

  9. Nontasut P, SinghasivAnon V, Prarinyanuparp V. Effect of single-dose albendazole and single-dose mebendazole on Necator americanus. Southeast Asian J Trop Med Public Health 1989; 20(2): 237–42

    PubMed  CAS  Google Scholar 

  10. Pugh RNH, Teesdale CH, Burnham GM. Albendazole in children with hookworm infection. Ann Trop Med Parasitol 1986; 80(5): 565–7

    PubMed  CAS  Google Scholar 

  11. Prasad R, Mathur PP, Taneja VK, et al. Albendazole in the treatment of intestinal helminthiasis in children. Clin Ther 1985; 7(2): 164–8

    PubMed  CAS  Google Scholar 

  12. Bwibo NO, Pamba HO. Double-blind comparative study of albendazole and placebo in the treatment of intestinal helminths. In: Firth M, editor. Albendazole in helminthiasis. Royal Society of Medicine International Congress and Symposium series no. 61, Royal Society of Medicine, 1984:47-53

  13. Chen ER, Yen CM, Shih CC, et al. Albendazole in the treatment of common intestinal parasite infections among school children in Taiwan. J Formos Med Assoc 1984; 83(6): 551–5

    CAS  Google Scholar 

  14. Coulaud JP, Rossignol JF. Albendazole: a new single dose anthelmintic; study in 1455 patients. Acta Trop 1984; 41(1): 87–90

    PubMed  CAS  Google Scholar 

  15. Chandiwana SK, Makaza D, Makura O. Study of albendazole in the treatment of intestinal helminthiasis in Zimbabwe. Cent Afr J Med 1983; 29(11): 213–5

    PubMed  CAS  Google Scholar 

  16. Chitchang S, Leelayoova S, Piamjinda T. Albendazole in treatment of hookworm infestation in Thailand. J Med Assoc Thai 1983; 66(1): 45–8

    PubMed  CAS  Google Scholar 

  17. Cruz O. Comparative evaluation of the effect of single doses of mebendazole and albendazole. Invest Med Int 1983; 10(5): 404–6

    Google Scholar 

  18. Kan SP, Chua SH. The anthelmintic effect of albendazole on Trichuris trichiuria and Ascaris lumbricoides. Asian J Clin Sci 1983; 4(3): 285–8

    Google Scholar 

  19. Morgan P, Yamamoto M, Teesdale C, et al. Albendazole: a new treatment for hookworm. Med Quarterly — J Med Assoc Malawi 1983; 16: 4–5

    Google Scholar 

  20. Albonico M, Renganathan E, Bosman A, et al. Efficacy of a single dose of mebendazole on prevalence and intensity of soil transmitted nematodes in Zanzibar. Trop Geogr Med 1994; 46: 142–6

    PubMed  CAS  Google Scholar 

  21. Ramirez Fernandez E, Miquet Romero L, Finlay C. Comparison of 3 single-dose mebendazole regimes for the treatment of trichuriasis. Rev Cubana Med Trop 1992; 44(1): 21–4

    PubMed  CAS  Google Scholar 

  22. Balasuriya S, Edirisinghe JS, Rajudeen NMM. Effectiveness of mass treatment with mebendazole in the control of soil transmitted helminths in Sri Lanka. Ceylon Med J 1990; 35(1): 15–20

    PubMed  CAS  Google Scholar 

  23. Abadi K. Single dose mebendazole therapy for soil-transmitted nematodes. Am J Trop Med Hyg 1985; 34(1): 129–33

    PubMed  CAS  Google Scholar 

  24. Farahmandian I, Sahba GH, Arfaa F, et al. Comparison of the effect of oxantel-pyrantel and mebendazole on soil-transmitted nematodes in Iran. Curr Ther Res 1979; 26(1): 114–8

    Google Scholar 

  25. Chongsuphajaisiddhi T, Sabcharoen A, Attanath P, et al. Treatment of soil-transmitted nematode infections in children with mebendazole. Ann Trop Med Parasitol 1978; 72(1): 59–63

    PubMed  CAS  Google Scholar 

  26. Lionel NDW, Rajapakse L, Soysa P, et al. Mebendazole in the treatment of intestinal helminthiasis with special reference to whipworm infection. J Trop Med Hyg 1975; 78(4): 75–7

    PubMed  CAS  Google Scholar 

  27. Vandepitte J, Gatti F, Lontie M, et al. Mebendazole, new broad spectrum anthelmintic agent against trichocephalosis. Bull Soc Path Exotique 1973; 66: 165–78

    CAS  Google Scholar 

  28. Ahmad A, Zohra A, Yasmin N. ‘Albendazole’ in intestinal helminthiasis. JPMA J Pak Med Assoc 1986; 36(5): 114–7

    PubMed  CAS  Google Scholar 

  29. Almeida ISD. Therapeutic action of mebendazole on multiple enteroparasitic infections in children in N.S. de Fatima -Planaltina — DF — 1978. Rev Inst Med Trop Sao Paulo 1979; 21(6): 339–43

    PubMed  Google Scholar 

  30. Amato Neto V, Moreira AAB, Campos R, et al. Treatment of hookworm, ascariasis and trichuriasis with albendazole or mebendazole. Rev Inst Med Trop Sao Paulo 1983; 25(6): 294–9

    PubMed  CAS  Google Scholar 

  31. Bassily S, El Masry NA, Trabolsi B, et al. Treatment of ancylostomiasis and ascariasis with albendazole. Ann Trop Med Parasitol 1984; 78(1): 81–2

    PubMed  CAS  Google Scholar 

  32. Bastidas G. Albendazol a dosis unica en nematodiasis intestinales multiples. Invest Med Int 1982; 9: 308–12

    Google Scholar 

  33. Blechman MG. Clinical effectiveness of mebendazole in the treatment of trichuriasis. Curr Ther Res 1975; 18(6): 800–3

    PubMed  CAS  Google Scholar 

  34. Bunnag D, Harinasuta T, Vasuvat C, et al. Clinical trial of mebendazole on whipworm and hookworm. J Med Assoc Thai 1978; 61(6): 319–22

    PubMed  CAS  Google Scholar 

  35. Camillo-Coura L, Soli A, Willcox H. Ensaio com Albendazol no tratamento de helmintiases intestinais em criancas. A Folha Medica 1984; 88 Suppl. 1: 225–8

    Google Scholar 

  36. Charoenlarp P, Waikagul J, Muennoo C, et al. Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections. Southeast Asian J Trop Med Public Health 1993; 24(4): 712–6

    PubMed  CAS  Google Scholar 

  37. Chien FL, Foon KLP, Hassan K. Efficacy of albendazole against the three common soil-transmitted helminthiases. Trop Biomed 1989; 6(2): 133–6

    Google Scholar 

  38. Chobanov RE, Khanbutaev SN, Pogosyan EA. Clinical and epidemiological efficacy of new anthelmintics in foci of ascariasis and trichuriasis. Med Parazitol (Mosk) 1981; 50(5): 55–9

    CAS  Google Scholar 

  39. Cortes R, Sanchez M, Espinoza G, et al. Albendazole in helminthiasis in children. Compend Invest Clin Latinoamer 1982; 2: 63–7

    Google Scholar 

  40. de Silva DG, Hettiarachchi SP, Fonseka PH. Albendazole in the treatment of geohelminth infections in children. Ceylon Med J 1989; 34(4): 185–9

    PubMed  Google Scholar 

  41. Gazder AJ, Roy J. Albendazole suspension in the treatment of intestinal helminthiasis in children. Curr Ther Res 1987; 41(3): 324–7

    Google Scholar 

  42. Hanjeet K, Mathias RG. The efficacy of treatment with albendazole. Acta Trop 1991; 50(2): 111–4

    PubMed  CAS  Google Scholar 

  43. Jaroonvesama N, Charoenlarp K, Muangmanee L. Mebendazole, a new broad spectrum anthelmintic. J Med Assoc Thai 1978; 61(12): 675–80

    PubMed  CAS  Google Scholar 

  44. Jidy MD, Abascal HF, Marcelo JCM, et al. Levamisole, mebendazole, thiabendazole: their efficacy as anthelmintics in African patients recently arrived in Cuba in the period 1987–1988. Rev Cubana Med Trop 1990; 42(2): 240–6

    Google Scholar 

  45. Kleiner M. Ensaio terapeutico com albendazol nas helmintiases intestinais — simples ou mistas. Arq Bras Med 1990; 64(1): 58–60

    Google Scholar 

  46. Marcondes J, Meira D, Gushiken T, et al. Tratamento das helmintiases intestinais com Albendazole em indivíduos habitantes do município de Humaitá, Estado do Amazonas. A Folha Medica 1984; 88 Suppl. 1: 241–5

    Google Scholar 

  47. Misra PK, Pande NK, Jagota SC. Albendazole in the treatment of intestinal helminthiasis in children. Curr Med Res Opin 1985; 9(8): 516–9

    PubMed  CAS  Google Scholar 

  48. Nahmias J, Kennet R, Goldsmith R, et al. Evaluation of albendazole, pyrantel, bephenium, pyrantel-praziquantel and pyrantel-bephenium for single-dose mass treatment of necatoriasis. Ann Trop Med Parasitol 1989; 83(6): 625–9

    PubMed  CAS  Google Scholar 

  49. Nontasut P, SinghasivAnon V, Maipanich W, et al. Comparative study of different doses of mebendazole in hookworm infection. Southeast Asian J Trop Med Public Health 1987; 18(2): 211–4

    PubMed  CAS  Google Scholar 

  50. Ochoa G, Guerra A, Arango B, et al. Tratamiento de helmintiasis intestinales con albendazol en ninos de una comunidad colombiana. Invest Med Int 1989; 16: 125–30

    Google Scholar 

  51. Oyediran A, Oyejide CO. Double-blind comparative study of a new anthelmintic albendazole, in the treatment of intestinal helminths. In: Firth M, editor. Albendazole in helminthiasis. Royal Society of Medicine International Congress and Symposium series no. 61, Royal Society of Medicine, 1984:69-76

  52. Pene P, Mojon M, Garin JP, et al. Albendazole: a new broad spectrum anthelmintic: double-blind multicenter clinical trial. Am J Trop Med Hyg 1982; 31(2): 263–6

    PubMed  CAS  Google Scholar 

  53. Pereira JFV, Ghosh HK, Conklin S, et al. Mebendazole therapy of whipworm infestation: a clinical trial. Med J Aust 1979; 1(4): 134–5

    PubMed  CAS  Google Scholar 

  54. Ramalingam S, Sinniah B, Krishnan U. Albendazole, an effective single dose, broad spectrum anthelmintic drug. Am J Trop Med Hyg 1983; 32(5): 984–9

    PubMed  CAS  Google Scholar 

  55. Rim H-J, Joo K-Y, Lee J-S, et al. Anthelmintic effects of albendazole (Zentel) against helminthic infections. Korean J Parasitol 1984; 9(1): 67–73

    Google Scholar 

  56. Sargent RG, Dotterer TD, Savory AM, et al. A clinical evaluation of the efficacy of mebendazole in the treatment of trichuriasis. South Med J 1975; 68(1): 38–40

    PubMed  CAS  Google Scholar 

  57. Schenone H, Galdames M, Inzunza E, et al. An oral suspension of mebendazole in the treatment of enterobiasis, ascariasis and trichuriasis in children: the therapeutic effectiveness of a single dose in enterobiasis. Bol Chil Parasitol 1976; 31: 3–4

    Google Scholar 

  58. Shiratsuchi MS, Levi GC, Amato Neto V, et al. Results of treatment of trichuriasis with mebendazole. Rev Inst Med Trop Sao Paulo 1975; 17(3): 206–9

    PubMed  CAS  Google Scholar 

  59. Singhal KC, Gupta MC, Saxena PN. A clinical trial with mebendazole in ascariasis and ankylostomiasis. J Assoc Physicians India 1975; 23(12): 903–7

    PubMed  CAS  Google Scholar 

  60. Sitthichareonchai P, Kulkumthorn M, Akarabovorn P. Clinical trial of a 400 mg dose of albendazole in hookworm infection in Chulalongkorn Hospital. Chulalongkorn Med J 1984; 28(8): 909–13

    Google Scholar 

  61. Soh CT, Lee BH, Min DY, et al. Clinical trial of Vermox (R) (mebendazole), a new broadspectrum anthelmintic. Yonsei Reports Trop Med 1974; 5(1): 148–52

    Google Scholar 

  62. Urquiaga J, Pavia N. Efficacy of albendazole against intestinal helminthiases. Invest Med Int 1982; 9(3): 266–9

    Google Scholar 

  63. Varma TK, Shinghal TN, Saxena M, et al. Studies on comparative efficacy of drug mebendazole and flubendazole as broad spectrum anthelmintics. Indian J Parasitol 1991; 15(2): 161–3

    CAS  Google Scholar 

  64. Viravan C, Migasena S, Bunnag D, et al. Clinical trial of albendazole in hookworm infection. Southeast Asian J Trop Med Public Health 1982; 13(4): 654–7

    PubMed  CAS  Google Scholar 

  65. Wesche D, Barnish G. A comparative study of the effectiveness of mebendazole (Janssen) and generically equivalent mebendazole (Nordia) in intestinal helminthiasis in Papua New Guinean children. P N G Med J 1994; 37(1): 7–11

    PubMed  CAS  Google Scholar 

  66. Zawde D. The treatment of intestinal helminthiasis with albendazole. Ethiop Med J 1987; 25(2): 83–6

    PubMed  CAS  Google Scholar 

  67. WHO. WHO Model Prescribing information - drugs used in parasitic diseases. 2nd edition. Geneva: WHO, 1995

    Google Scholar 

  68. Chunlertrith K, Mairiang P, Sukeepaisarnjaroen W. Intestinal capillariasis: a cause of chronic diarrhea and hypoalbuminemia. Southeast Asian J Trop Med Public Health 1992; 23(3): 433–6

    PubMed  CAS  Google Scholar 

  69. Dronda F, Chaves F, Sanz A, et al. Human intestinal capillariasis in an area of nonendemicity: case report and review. Clin Infect Dis 1993; 17(5): 909–12

    PubMed  CAS  Google Scholar 

  70. Mousa AM, Rudwan MA, Marafi AA, et al. Human cystic hydatid disease: treatment with interrupted courses of mebendazole. J Trop Med Hyg 1986; 89(5): 257–64

    PubMed  CAS  Google Scholar 

  71. Teggi A, Lastilla MG, De Rosa F. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob Agents Chemother 1993; 37(8): 1679–84

    PubMed  CAS  Google Scholar 

  72. Mravak S, Schopp W, Bienzle U. Treatment of strongyloidiasis with mebendazole. Acta Trop 1983; 40(1): 93–4

    PubMed  CAS  Google Scholar 

  73. Shikiya K, Zaha O, Niimura S, et al. Clinical study on ivermectin against 125 strongyloidiasis patients. Kansenshogaku Zasshi 1994; 68(1): 13–20

    PubMed  CAS  Google Scholar 

  74. Mittermayer T, Spaldonova R. The use of mebendazole in the treatment of trichinellosis in man. Folia Parasitol Praha 1981; 28(3): 235–42

    PubMed  CAS  Google Scholar 

  75. Levin ML. Treatment of trichinosis with mebendazole. Am J Trop Med Hyg 1983; 32(5): 980–3

    PubMed  CAS  Google Scholar 

  76. Magnaval JF, Charlet JP. Comparative efficacy of thiabendazole and mebendazole in the treatment of toxocariasis. Therapie 1987; 42(6): 541–4

    PubMed  CAS  Google Scholar 

  77. Magnaval JF, Charlet JP, de Larrard B. Double blind study of the efficacy of mebendazole in minor forms of human toxocariasis. Therapie 1992; 47(2): 145–8

    PubMed  CAS  Google Scholar 

  78. Magnaval JF. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis. Parasi-tology 1995; 110(5): 529–33

    Google Scholar 

  79. Wahlgren M. The successful treatment of Dipetalonema perstans filariasis with mebendazole. Ann Trop Med Parasitol 1982; 76(5): 557–9

    PubMed  CAS  Google Scholar 

  80. Van Hoegaerden M, Ivanoff B, Flocard F, et al. The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 1987; 81(3): 275–82

    PubMed  Google Scholar 

  81. Chavarria AP, Villarejos VM, Zeledon R. Mebendazole in the treatment of taeniasis solium and taeniasis saginata. Am J Trop Med Hyg 1977; 26(1): 118–20

    PubMed  CAS  Google Scholar 

  82. Khalil HM, el Shimi S, Sarwat MA, et al. Recent study of Hymenolepis nana infection in Egyptian children. J Egypt Soc Parasitol 1991; 21(1): 293–300

    PubMed  CAS  Google Scholar 

  83. Reynolds JEF, editor. Martindale: the extra pharmacopoeia. 30th edition. London: Pharmaceutical Press, 1993

    Google Scholar 

  84. Seitz R, Schwerk W, Arnold R. Hepatocellular drug reaction caused by mebendazole therapy in cystic echinococcosis. Z Gastroenterol 1983; 21(7): 324–9

    PubMed  CAS  Google Scholar 

  85. Bekhti A, Pirotte J. Cimetidine increases serum mebendazole concentrations: implications for treatment of hepatic hydatid cysts. Br J Clin Pharmacol 1987; 24: 390–2

    PubMed  CAS  Google Scholar 

  86. Miskovitz PF, Javitt NB. Leukopenia associated with mebendazole therapy of hydatid disease. Am J Trop Med Hyg 1980; 29(6): 1356–8

    PubMed  CAS  Google Scholar 

  87. Levin MH, Weinstein RA, Axelrod JL, et al. Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis. Jama 1983; 249(21): 2929–31

    PubMed  CAS  Google Scholar 

  88. Kammerer WS, Schantz PM. Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. Am J Trop Med Hyg 1984; 33(1): 132–7

    PubMed  CAS  Google Scholar 

  89. Braithwaite PA, Thomas RJ, Thompson RC. Hydatid disease: the alveolar variety in Australia: a case report with comment on the toxicity of mebendazole. Aust N Z J Surg 1985; 55(5): 519–23

    PubMed  CAS  Google Scholar 

  90. Fernandez Banares F, Gonzalez Huix F, Xiol X, et al. Marrow aplasia during high dose mebendazole treatment. Am J Trop Med Hyg 1986; 35(2): 350–1

    PubMed  CAS  Google Scholar 

  91. Abdi Y, Gustaffson L, Ericsson O, et al. Handbook of drugs for tropical parasitic infections. 2nd ed. London: Taylor and Francis, 1995

    Google Scholar 

  92. Bogan JA, Marriner SE. Analysis of benzimidazoles in body fluids by high performance liquid chromatography. J Pharmacol Sci 1980; 69: 122–3

    Google Scholar 

  93. Hall A, Nahar Q. Albendazole and infections with Ascaris lumbricoides and Trichuris trichiura in children in Bangladesh. Trans R Soc Trop Med Hyg 1994; 88(1): 110–2

    PubMed  CAS  Google Scholar 

  94. Pitisuttithum P, Suparanond W, Chindanond D. A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. Southeast Asian J Trop Med Public Health 1995; 26: 735–8

    PubMed  CAS  Google Scholar 

  95. Datry A, Hilmarsdottir I, Mayorga Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88(3): 344–5

    PubMed  CAS  Google Scholar 

  96. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169(5): 1076–9

    PubMed  CAS  Google Scholar 

  97. Archibald LK, Beeching NJ, Gill GV, et al. Albendazole is effective treatment for chronic strongyloidiasis. Q J Med 1993; 86(3): 191–5

    PubMed  CAS  Google Scholar 

  98. Niimura S, Hirata T, Zaha O, et al. Clinical study of albendazole therapy for strongyloidiasis. Kansenshogaku Zasshi 1992; 66(9): 1231–5

    PubMed  CAS  Google Scholar 

  99. Cross JH, Basaca Sevilla V. Albendazole in the treatment of intestinal capillariasis. Southeast Asian J Trop Med Public Health 1987; 18(4): 507–10

    PubMed  CAS  Google Scholar 

  100. Chichino G, Bernuzzi AM, Bruno A, et al. Intestinal capillariasis (Capillaria philippinensis acquired in Indonesia: a case report. Am J Trop Med Hyg 1992; 47(1): 10–2

    PubMed  CAS  Google Scholar 

  101. Lee SH, Hong ST, Chai J Y, et al. A case of intestinal capillariasis in the Republic of Korea. Am J Trop Med Hyg 1993; 48(4): 542–6

    PubMed  CAS  Google Scholar 

  102. Hong ST, Kim YT, Choe G, et al. Two cases of intestinal capillariasis in Korea. Korean J Parasitol 1994; 32(1): 43–8

    PubMed  CAS  Google Scholar 

  103. de Kaminsky RG. Albendazole treatment in human taeniasis. Trans R Soc Trop Med Hyg 1991; 85(5): 648–50

    PubMed  Google Scholar 

  104. Cruz M, Cruz I, Horton J. Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation. Trans R Soc Trop Med Hyg 1991; 85(2): 244–7

    PubMed  CAS  Google Scholar 

  105. Takayanagui OM, Jardim E. Therapy for neurocysticercosis. Comparison between albendazole and praziquantel. Arch Neurol 1992; 49(3): 290–4

    PubMed  CAS  Google Scholar 

  106. Botero D, Uribe CS, Sanchez JL, et al. Short course albendazole treatment for neurocysticercosis in Columbia. Trans R Soc Trop Med Hyg 1993; 87(5): 576–7

    PubMed  CAS  Google Scholar 

  107. Martinez HR, Rangel Guerra R, Arredondo Estrada JH, et al. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases. J Neurol Sci 1995; 130(1): 25–34

    PubMed  CAS  Google Scholar 

  108. Kraivichian P, Kulkumthorn M, Yingyourd P, et al. Albendazole for the treatment of human gnathostomiasis. Trans R Soc Trop Med Hyg 1992; 86(4): 418–21

    PubMed  CAS  Google Scholar 

  109. Meneghelli UG, Martinelli AL, Bellucci AD, et al. Polycystic hydatid disease (Echinococcus vogeli): treatment with albendazole. Ann Trop Med Parasitol 1992; 86(2): 151–6

    PubMed  CAS  Google Scholar 

  110. el Mufti M, Kamag A, Ibrahim H, et al. Albendazole therapy of hydatid disease: 2-year follow-up of 40 cases. Ann Trop Med Parasitol 1993; 87(3): 241–6

    PubMed  Google Scholar 

  111. Gil Grande LA, Rodriguez Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intraabdominal hydatid disease. Lancet 1993; 342(8882): 1269–72

    PubMed  CAS  Google Scholar 

  112. Liu YH, Wang XG, Chen YT, et al. Computer tomography of liver in alveolar echinococcosis treated with albendazole. Trans R Soc Trop Med Hyg 1993; 87(3): 319–21

    PubMed  CAS  Google Scholar 

  113. Wen H, Zhang HW, Muhmut M, et al. Initial observation on albendazole in combination with cimetidine for the treatment of human cystic echinococcosis. Ann Trop Med Parasitol 1994; 88(1): 49–52

    PubMed  CAS  Google Scholar 

  114. Torres JR, Orihuela AR, Garcia D, et al. Treatment of cutaneous larva migrans with albendazole: preliminary report. Rev Inst Med Trop Sao Paulo 1989; 31(1): 56–8

    PubMed  CAS  Google Scholar 

  115. Caumes E, Carriere J, Datry A, et al. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993; 49(5): 641–4

    PubMed  CAS  Google Scholar 

  116. Kollaritsch H, Jeschko E, Wiedermann G. Albendazole is highly effective against cutaneous larva migrans but not against Giardia infection: results of an open pilot trial in travellers returning from the tropics. Trans R Soc Trop Med Hyg 1993; 87(6): 689

    PubMed  CAS  Google Scholar 

  117. Sturchler D, Schubarth P, Gualzata M, et al. Thiabendazole vs. albendazole in treatment of toxocariasis: a clinical trial. Ann Trop Med Parasitol 1989; 83(5): 473–8

    PubMed  CAS  Google Scholar 

  118. Bhatia V, Sarin SK. Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol 1994; 89(4): 624–7

    PubMed  CAS  Google Scholar 

  119. Pungpark S, Bunnag D, Harinasuta T. Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections. Southeast Asian J Trop Med Public Health 1984; 15(1): 44–50

    PubMed  CAS  Google Scholar 

  120. Liu YH, Wang XG, Gao P, et al. Experimental and clinical trial of albendazole in the treatment of Clonorchiasis sinensis. Chin Med J Engl 1991; 104(1): 27–31

    PubMed  CAS  Google Scholar 

  121. Fourestie V, Bougnoux ME, Ancelle T, et al. Randomized trial of albendazole versus tiabendazole plus flubendazole during an outbreak of human trichinellosis. Parasitol Res 1988; 75(1): 36–41

    PubMed  CAS  Google Scholar 

  122. Xu B, Chang J, Gao G, et al. Four outbreaks of human trichinellosis in Henan Province. Chin Med J (Engl) 1995; 108(11): 872–4

    CAS  Google Scholar 

  123. Awadzi K, Hero M, Opoku O, et al. The chemotherapy of onchocerciasis. XV. Studies with albendazole. Trop Med Parasitol 1991; 42(4): 356–60

    PubMed  CAS  Google Scholar 

  124. Cline BL, Hernandez JL, Mather FJ, et al. Albendazole in the treatment of onchocerciasis: double-blind clinical trial in Venezuela. Am J Trop Med Hyg 1992; 47(4): 512–20

    PubMed  CAS  Google Scholar 

  125. Klion AD, Massougbodji A, Horton J, et al. Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis 1993; 168(1): 202–6

    PubMed  CAS  Google Scholar 

  126. Morris DL, Smith PG. Albendazole in hydatid disease -hepatocellular toxicity. Trans R Soc Trop Med Hyg 1987; 81(2): 343–4

    PubMed  CAS  Google Scholar 

  127. Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 1989; 83(1): 97–102

    PubMed  CAS  Google Scholar 

  128. Steiger U, Cotting J, Reichen J. Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance. Clin Pharmacol Ther 1990; 47(3): 347–53

    PubMed  CAS  Google Scholar 

  129. Hewitt RI, Kushner S, Stewart H, et al. Experimental chemotherapy of filariasis III. Effect of 1 -diethylcarbamyl-4-methylpiperazine hydrochloride against naturally acquired filarial infection in cotton rats and dogs. J Lab Clin Med 1947; 32: 1314–29

    PubMed  CAS  Google Scholar 

  130. Gelband H. Diethylcarbamazine salt in the control of lymphatic filariasis. Am J Trop Med Hyg 1994; 50(6): 655–62

    PubMed  CAS  Google Scholar 

  131. Adjepon-Yamoah KK, Edwards G, Breckenridge AM, et al. The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man. Br J Clin Pharmacol 1982; 13: 829–34

    PubMed  CAS  Google Scholar 

  132. Langham ME, Kramer TR. The ‘in vitro’ effect of diethylcarbamazine on the motility and survival of Onchocerca volvulus microfilariae. Tropenmed Parasitol 1980; 31(1): 59–66

    PubMed  CAS  Google Scholar 

  133. Cesbron JY, Capron A, Vargaftig BB, et al. Platelets mediate the action of diethylcarbamazine on microfilariae. Nature 1987; 325(6104): 533–6

    PubMed  CAS  Google Scholar 

  134. Maizels RM, Denham DA. Diethylcarbamazine (DEC): immunopharmacological interactions of an anti-filarial drug. Parasitology 1992; 105: S49–60

    PubMed  Google Scholar 

  135. Maizels RM, Bundy DAP, Selkirk ME, et al. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993; 365: 797–805

    PubMed  CAS  Google Scholar 

  136. Fujimaki Y, Ehara M, Kimura E, et al. Diethylcarbamazine, antifilarial drug, inhibits microtubule polymerization and disrupts preformed microtubules. Biochem Pharmacol 1990; 39(5): 851–6

    PubMed  CAS  Google Scholar 

  137. Figueredo-Silva J, Jungmann P, Noroes J, et al. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis. Trans R Soc Trop Med Hyg 1996; 90: 192–4

    PubMed  CAS  Google Scholar 

  138. Gilles HM. Soil-transmitted helminths (geohelminths). In: Cook GC, editor. Manson’s tropical diseases. 20 edition. London: WB Saunders Company, 1996: 1369–412

    Google Scholar 

  139. Dreyer G, Pires ML, de Andrade LD, et al. Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil. Trans R Soc Trop Med Hyg 1994; 88(2): 232–6

    PubMed  CAS  Google Scholar 

  140. Albiez EJ, Newland HS, White AT, et al. Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects. Trop Med Parasitol 1988; 39(1): 19–24

    PubMed  CAS  Google Scholar 

  141. Carme B, Boulesteix J, Boutes H, et al. Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg 1991; 44: 684–90

    PubMed  CAS  Google Scholar 

  142. Goa KL, McTavish D, Clissold SP. Ivermectin: a review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs 1991; 42: 640–58

    PubMed  CAS  Google Scholar 

  143. Ottesen EA, Campbell WC. Ivermectin in human medicine. J Antimicrob Chemother 1994; 34(2): 195–203

    PubMed  CAS  Google Scholar 

  144. Whitworth JAG. Filariases. Curr Opin Infect Dis 1994; 7: 696–700

    Google Scholar 

  145. Boussinesq M, Chippaux JP, Ernould JC, et al. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon. Am J Trop Med Hyg 1995; 53(1): 63–7

    PubMed  CAS  Google Scholar 

  146. Kumaraswami V, Ottesen EA, Vijayasekaran V, et al. Ivermectin for the treatment of Wuchereria bancrofti filariasis: efficacy and adverse reactions [published erratum appears in JAMA 1988 Aug 5; 260 (5): 640]. JAMA 1988; 259(21): 3150–3

    PubMed  CAS  Google Scholar 

  147. Coutinho AD, Dreyer G, Modeiros Z, et al. Ivermectin treatment of bancroftian filariasis in Recife, Brazil. Am J Trop Med Hyg 1994; 50: 339–48

    PubMed  CAS  Google Scholar 

  148. Moulia-Pelat J-P, Glaziou P, Nguyen LN, et al. Ivermectin 400 mcg/kg: long-term suppression of microfilariae in bancroftian filariasis. Tran R Soc Trop Med Hyg 1994; 88: 107–9

    CAS  Google Scholar 

  149. Shenoy RK, Kumaraswami V, Rajan K, et al. A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis. Ann Trop Med Parasitol 1993; 87(5): 459–67

    PubMed  CAS  Google Scholar 

  150. Richard Lenoble D, Kombila M, Rupp EA, et al. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am J Trop Med Hyg 1988; 39(5): 480–3

    PubMed  CAS  Google Scholar 

  151. Martin Prevel Y, Cosnefroy JY, Tshipamba P, et al. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis. Am J Trop Med Hyg 1993; 48(2): 186–92

    PubMed  CAS  Google Scholar 

  152. Ducorps M, Gardon Wendel N, Ranque S, et al. Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin. Bull Soc Pathol Exot 1995; 88(3): 105–2

    PubMed  CAS  Google Scholar 

  153. Nutman TB, Nash TE, Ottesen EA. Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection. J Infect Dis 1987; 156(4): 662–5

    PubMed  CAS  Google Scholar 

  154. Dreyer G, Noroes J, Amaral F, et al. Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89(4): 441–3

    PubMed  CAS  Google Scholar 

  155. Torres JR, Isturiz R, Murillo J, et al. Efficacy of ivermectin in the treatment of strongyloidiasis complicating AIDS. Clin Infect Dis 1993; 17(5): 900–2

    PubMed  CAS  Google Scholar 

  156. Whitworth JA, Morgan D, Maude GH, et al. A field study of the effect of ivermectin on intestinal helminths in man. Trans R Soc Trop Med Hyg 1991; 85(2): 232–4

    PubMed  CAS  Google Scholar 

  157. Xia ZH, Su YL, Yao SY, et al. Clinical observation on efficacy of ivermectin in the treatment of intestinal nematode infections. Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih 1992; 10(4): 279–82

    PubMed  CAS  Google Scholar 

  158. Behnke JM, Pritchard DI, Wakelin D, et al. Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone. J Helminthol 1994; 68(3): 187–95

    PubMed  CAS  Google Scholar 

  159. Pacque M, Munoz B, Greene BM, et al. Safety of and compliance with community-based ivermectin therapy. Lancet 1990; 335(8702): 1377–80

    PubMed  CAS  Google Scholar 

  160. De Sole G, Awadzi K, Remme J, et al. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II: adverse reactions. Trop Med Parasitol 1989; 40(3): 375–82

    PubMed  Google Scholar 

  161. Pacque M, Munoz B, Poetschke G, et al. Pregnancy outcome after inadvertent ivermectin treatment during communitybased distribution. Lancet 1990; 336(8729): 1486–9

    PubMed  CAS  Google Scholar 

  162. King CH, Lombardi G, Lombardi C, et al. Chemotherapy-based control of schistosomiasis haematobia. I: metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 1988; 39(3): 295–305

    PubMed  CAS  Google Scholar 

  163. Taddese K, Zein ZA. Comparison between the efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infections on a sugar estate in Ethiopia. Ann Trop Med Parasitol 1988; 82(2): 175–80

    PubMed  CAS  Google Scholar 

  164. Stephenson LS, Kinoti SN, Latham MC, et al. Single dose metrifonate or praziquantel treatment in Kenyan children. I: effects on Schistosoma haematobium, hookworm, hemoglobin levels, splenomegaly, and hepatomegaly. Am J Trop Med Hyg 1989; 41(4): 436–4

    PubMed  CAS  Google Scholar 

  165. King CH, Muchiri E, Ouma JH, et al. Chemotherapy-based control of Schistosoma haematobium. IV: impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 1991; 45(4): 498–508

    PubMed  CAS  Google Scholar 

  166. Wu MH, Wei CC, Xu ZY, et al. Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonica. Am J Trop Med Hyg 1991; 45(3): 345–9

    PubMed  CAS  Google Scholar 

  167. Metwally A, Bennett J, Botros S, et al. Impact of drug dosage and brand on bioavailability and efficacy of praziquantel. Pharmacol Res 1995; 31(1): 53–9

    PubMed  CAS  Google Scholar 

  168. Yangco BG, De Lerma C, Lyman GH, et al. Clinical study evaluating efficacy of praziquantel in clonorchiasis. Antimicrob Agents Chemother 1987; 31(2): 135–8

    PubMed  CAS  Google Scholar 

  169. Kieu TL, Bronshtein AM, Sabgaida TP. Clonorchiasis in the People’s Republic of Vietnam. 2: the clinico-parasitological examination of a focus and a trial of praziquantel treatment. Med Parazitol (Mosk) 1992; 4: 7–11

    Google Scholar 

  170. Wang XG, Liu YH, Yan XH. A comparative trial of levopraziquantel and praziquantel in the treatment of human Clonorchis sinensis infection. Chung Hua Nei Ko Tsa Chih 1992; 31(4): 233–5, 256

    PubMed  CAS  Google Scholar 

  171. Li S, He G, Lu Z, et al. Efficacy of praziquantel combined with albendazole in the treatment of clonorchiasis. Chung Kuo Chi Sheng Chung Hsueh Yu Chi Sheng Chung Ping Tsa Chih 1995; 13(1): 61–3

    PubMed  CAS  Google Scholar 

  172. Udonsi JK. Clinical field trials of praziquantel in pulmonary paragonimiasis due to Paragonimus uterobilateralis in endemic populations of the Igwun Basin, Nigeria. Trop Med Parasitol 1989; 40(1): 65–8

    PubMed  CAS  Google Scholar 

  173. Farag HF, Ragab M, Salem A, et al. A short note on praziquantel in human fascioliasis. J Trop Med Hyg 1986; 89(2): 79–80

    PubMed  CAS  Google Scholar 

  174. Fan PC, Chung WC, Chan CH, et al. Studies on taeniasis in Taiwan. V. Field trial on evaluation of therapeutic efficacy of mebendazole and praziquantel against taeniasis. Southeast Asian J Trop Med Public Health 1986; 17(1): 82–90

    PubMed  CAS  Google Scholar 

  175. Carpio A, Santillan F, Leon P, et al. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995; 155(18): 1982–8

    PubMed  CAS  Google Scholar 

  176. Davis A, Biles JE, Ulrich AM. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium. Bull World Health Organ 1979; 57: 773–9

    PubMed  CAS  Google Scholar 

  177. Dollery C, ed. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1991

    Google Scholar 

  178. Savioli L, Bundy D, Tomkins A. Intestinal parasitic infections: a soluble public health problem. Trans R Soc Trop Med Hyg 1992; 86: 353–4

    PubMed  CAS  Google Scholar 

  179. Thein H, Thane T, Than S, et al. A controlled chemotherapeutic intervention trial on the relationship between Ascaris lumbricoides infection and malnutrition in children. Trans R Soc Trop Med Hyg 1991; 85(4): 523–8

    Google Scholar 

  180. Stephenson L, Latham M, Adams E, et al. Weight gain of Kenyan school children infected with hookworm, Trichuris trichiura and Ascaris lumbricoides is improved following once- or twice-yearly treatment with albendazole. J Nutr 1993; 123: 656–65

    PubMed  CAS  Google Scholar 

  181. Stephenson L, Latham M, Adams E, et al. Physical fitness, growth and appetite of Kenyan schoolboys with hookworm, Trichuris trichiura and Ascaris lumbricoides infections are improved four months after a single dose of albendazole. J Nutr 1993; 123: 1036–46

    PubMed  CAS  Google Scholar 

  182. Nokes C, Bundy D. Does helminth infection affect mental processing and educational achievement? Parasitol Today 1994; 10(1): 14–8

    PubMed  CAS  Google Scholar 

  183. Guyatt H, Chan M, Medley G, et al. Control of Ascaris infection by chemotherapy: which is the most cost-effective option? Trans R Soc Trop Med Hyg 1995; 89: 16–20

    PubMed  CAS  Google Scholar 

  184. Albonico M, Smith PG, Ercole E, et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995; 89(5): 538–41

    PubMed  CAS  Google Scholar 

  185. Bundy DA, Wong MS, Lewis LL, et al. Control of geohelminths by delivery of targeted chemotherapy through schools. Trans R Soc Trop Med Hyg 1990; 84(1): 115–20

    PubMed  CAS  Google Scholar 

  186. Cartel JL, Spiegel A, Nguyen Ngnoc L, et al. Compared efficacy of repeated annual and semi-annual doses of ivermectin and diethylcarbamazine for prevention of Wuchereria bancrofti filariasis in French Polynesia. Final evaluation. Trop Med Parasitol 1992; 43(2): 91–4

    PubMed  CAS  Google Scholar 

  187. Glaziou P, Moulia Pelat JP, et al. Double-blind controlled trial of a single dose of the combination ivermectin 400 micrograms/kg plus diethylcarbamazine 6 mg/kg for the treatment of bancroftian filariasis: results at six months. Trans R Soc Trop Med Hyg 1994; 88(6): 707–8

    PubMed  CAS  Google Scholar 

  188. Moulia Pelat JP, Nguyen LN, Hascoet H, et al. Advantages of an annual single dose of ivermectin 400 micrograms/kg plus diethylcarbamazine for community treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 1995; 89(6): 682–5

    PubMed  CAS  Google Scholar 

  189. Addiss DG, Eberhard ML, Lammie PJ, et al. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia. Am J Trop Med Hyg 1993; 48(2): 178–85

    PubMed  CAS  Google Scholar 

  190. Andrade LD, Medeiros Z, Pires ML, et al. Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis. Trans R Soc Trop Med Hyg 1995; 89(3): 319–21

    PubMed  CAS  Google Scholar 

  191. Dreyer G, Coutinho A, Miranda D, et al. Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine. Trans R Soc Trop Med Hyg 1995; 89(1): 98–102

    PubMed  CAS  Google Scholar 

  192. Meyrowitsch DW, Simonsen PE, Makunde WH. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments. Trans R Soc Trop Med Hyg 1996; 90: 69–73

    PubMed  CAS  Google Scholar 

  193. Mak JW, Navaratnam V, Grewel JS, et al. Treatment of sub-periodic Brugia malayi infection with a single dose of ivermectin. Am J Trop Med Hyg 1993; 48(4): 591–6

    PubMed  CAS  Google Scholar 

  194. Hakim SL, Vythilingam I, Marzukhi MI, et al. Single-dose diethylcarbamazine in the control of periodic brugian filariasis in Peninsular Malaysia. Trans R Soc Trop Med Hyg 1995; 89(6): 686–9

    PubMed  CAS  Google Scholar 

  195. Reddy GS, Sambasivam V, Venkateswaralu N. Control of bancroftian filariasis by salt medicated with diethylcarbamazine citrate. J Indian Med Assoc 1986; 84(1): 1–3

    PubMed  CAS  Google Scholar 

  196. Narasimham MV, Sharma SP, Sundaram RM, et al. Control of bancroftian filariasis by diethylcarbamazine medicated common salt in Karaikal, Pondicherry, India. J Commun Dis 1989; 21(3): 157–70

    PubMed  CAS  Google Scholar 

  197. Liu J, Chen Z, Huang X, et al. Mass treatment of filariasis using DEC-medicated salt. J Trop Med Hyg 1992; 95(2): 132–5

    PubMed  CAS  Google Scholar 

  198. Casley Smith JR, Jamal S, Casley Smith J. Reduction of filaritic lymphoedema and elephantiasis by 5,6 benzo-alpha-pyrone (coumarin), and the effects of diethylcarbamazine (DEC). Ann Trop Med Parasitol 1993; 87(3): 247–58

    PubMed  CAS  Google Scholar 

  199. Cupp EW, Ochoa JO, Collins RC, et al. The effects of repetitive community-wide ivermectin treatment on transmission of Onchocerca volvulus in Guatemala. Am J Trop Med Hyg 1992; 47(2): 170–80

    PubMed  CAS  Google Scholar 

  200. Alley ES, Plaisier AP, Boatin BA, et al. The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg 1994; 88(5): 581–4

    PubMed  CAS  Google Scholar 

  201. Baraka OZ, Khier MM, Ahmed KM, et al. Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions. Trans R Soc Trop Med Hyg 1995; 89(3): 316–8

    PubMed  CAS  Google Scholar 

  202. Baraka OZ, Mahmoud BM, Ali MM, et al. Ivermectin treatment in severe asymmetric reactive onchodermatitis (sowda) in Sudan. Trans R Soc Trop Med Hyg 1995; 89(3): 312–5

    PubMed  CAS  Google Scholar 

  203. Burnham G. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. Am J Trop Med Hyg 1995; 52(3): 270–6

    PubMed  CAS  Google Scholar 

  204. Rodriguez Perez MA, Rodriguez MH, Margeli Perez HM, et al. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico. Am J Trop Med Hyg 1995; 52(5): 429–34

    PubMed  CAS  Google Scholar 

  205. Warren KS, Bundy DAP, Anderson RM, et al. Helminth infections. In Disease control priorities in devloping countries. Jamison DT, Mosley WH, Measham AR et al., editors. Oxford: Oxford University Press 1993: 131–60

    Google Scholar 

  206. WHO. The control of schistosomiasis. WHO Technical Report Series 830. Geneva: WHO, 1993

    Google Scholar 

  207. Homeida MA, Daffalla A A, Nash TE. Effect of antischistosomal chemotherapy on prevalence of Symmer’s periportal fibrosis in Sudanese villages. Lancet 1988; II: 437–40

    Google Scholar 

  208. Homeida MA, Al Tom I, Nash T, et al. Assocaition of the therapeutic activity of praziquantel with the reversal of Symmer’s fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 1991; 45: 360–5

    PubMed  CAS  Google Scholar 

  209. Butterworth AE, Sturrock RF, Ouma JH, et al. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. Parasitology 1991; 103: 339–55

    PubMed  Google Scholar 

  210. Lengeler C, de Savigny D, Mshinda H, et al. Community-based questionnaires and health statistics as tools for the costefficainet identification of communities at risk of urinary schistosomiasis. Int J Epidemiol 1991; 20: 796–807

    PubMed  CAS  Google Scholar 

  211. Guyatt HL, Evans D, Lengeler C, et al. Controlling schistosomiasis: the cost-effectiveness of alterantive delivery strategies. Health Policy Plan 1994; 9: 385–95

    PubMed  CAS  Google Scholar 

  212. Vivatanasesth P, Sommani S, Schelp FP, et al. Mass treatment of opisthorchiasis in Northeast Thailand. Southeast Asian J Trop Med Public Health 1982; 13(4): 609–13

    PubMed  CAS  Google Scholar 

  213. Zavoikin VD, Zelia OP, Bronshtein AM, et al. The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 1: the tolerance and efficacy of different doses of biltricide during outpatient use in foci. Med Parazitol (Mosk) 1994 Jul–Sep; (3): 24–7

  214. Bunnag D, Radomyos P, Harinasuta T. Field trial on the treatment of fasciolopsiasis with praziquantel. Southeast Asian J Trop Med Public Health 1983; 12(2): 216–9

    Google Scholar 

  215. Benjapong W, Naeypatimanond S, Benjapong K, et al. Studies on paragonimiasis: treatment with mebendazole, emetine with mebendazole and praziquantel. Southeast Asian J Trop Med Public Health 1984; 15(3): 354–9

    PubMed  CAS  Google Scholar 

  216. Hammouda NA, el Mansoury ST, el Azzouni MZ, et al. Therapeutic effect of triclabendazole in patients with fascioliasis in Egypt: a preliminary study. J Egypt Soc Parasitol 1995; 15(1): 137–43

    Google Scholar 

  217. Lee SH. Large scale treatment of Clonorchis sinensis infections with praziquantel under field conditions. Arzneimittel Forschung 1984; 34(9B): 1227–30

    PubMed  CAS  Google Scholar 

  218. Cruz I, Cruz ME, Carrasco F, et al. Neurocysticercosis: optimal dose treatment with albendazole. J Neurol Sci 1995; 133(1-2): 152–4

    PubMed  CAS  Google Scholar 

  219. Escobedo F, Penagos P, Rodriguez J, et al. Albendazole therapy for neurocysticercosis. Arch Intern Med 1987; 147: 738–41

    PubMed  CAS  Google Scholar 

  220. Bryceson ADM, Cowie AGA, Macleod C, et al. Experience with mebendazole in the treatment of inoperable hydatid disease in England. Trans R Soc Trop Med Hyg 1982; 76: 510–8

    PubMed  CAS  Google Scholar 

  221. Ammann R, Tschudi K, von Ziegler M, et al. The long-term course of 60 patients with alveolar echinococcosis in continuous therapy with mebendazole (1976-85). Klin Wochenschr 1988; 66: 1060–73

    PubMed  CAS  Google Scholar 

  222. Bartoloni C, Tricerri A, Guidi L, et al. The efficacy of chemotherapy with mebendazole in human cystic echinococcosis: long-term follow-up of 52 patients. Ann Trop Med Parasitol 1992; 86(3): 249–56

    PubMed  CAS  Google Scholar 

  223. Wen H, Zou PF, Yang WG, et al. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China. Trans R Soc Trop Med Hyg 1994; 88(3): 340

    PubMed  CAS  Google Scholar 

  224. Luder PJ, Siffert B, Witassek F, et al. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. Eur J Clin Pharmacol 1986; 31: 443–8

    PubMed  CAS  Google Scholar 

  225. WHO. Health of school children: treatment of intestinal helminths and schistosomiasis. 1995 WHO/SCHISTO/95.112, WHO/CDS/95.1

  226. Shepard TH. Catalog of teratogenic agents. 4th ed. Baltimore: Johns Hopkins Hospital, 1983

    Google Scholar 

  227. Auer H, Kollaritsch H, Juptner J, et al. Albendazole and pregnancy. Appl Parasitol 1994; 35(2): 146–7

    PubMed  CAS  Google Scholar 

  228. Frohberg H. Results of toxicological studies on praziquantel. Arzneimittelforschung 1984; 34: 1137–44

    PubMed  CAS  Google Scholar 

  229. Dorny P, Claerebout E, Vercruysse J, et al. Anthelmintic resistance in goats in peninsular Malaysia. Vet Parasitol 1994; 55(4): 327–42

    PubMed  CAS  Google Scholar 

  230. Grimshaw WT, Hunt KR, Hong C, et al. Detection of anthelmintic resistant nematodes in sheep in southern England by a faecal egg count reduction test. Vet Rec 1994; 135(16): 372–4

    PubMed  CAS  Google Scholar 

  231. Overend DJ, Phillips ML, Poulton AL, et al. Anthelmintic resistance in Australian sheep nematode populations. Aust Vet J 1994; 71(4): 117–21

    PubMed  CAS  Google Scholar 

  232. Pandey VS, Sivaraj S. Anthelmintic resistance in Haemonchus contortus from sheep in Malaysia. Vet Parasitol 1994; 53(1-2): 67–74

    PubMed  CAS  Google Scholar 

  233. Rahman WA. Resistance to benzimidazole anthelmintics by Haemonchus contortus in goats in peninsular Malaysia. Vet Parasitol 1994; 55(1-2): 155–7

    PubMed  CAS  Google Scholar 

  234. Sivaraj S, Dorny P, Vercruysse J, et al. Multiple and multigeneric anthelmintic resistance on a sheep farm in Malaysia. Vet Parasitol 1994; 55(1-2): 159–65

    PubMed  CAS  Google Scholar 

  235. Vermunt JJ, West DM, Pomroy WE. Multiple resistance to ivermectin and oxfendazole in Cooperia species of cattle in New Zealand. Vet Rec 1995; 137(2): 43–5

    PubMed  CAS  Google Scholar 

  236. Echevarria F, Borba MF, Pinheiro AC, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Brazil. Vet Parasitol 1996; 62(3-4): 199–206

    PubMed  CAS  Google Scholar 

  237. Eddi C, Caracostantogolo J, Pena M, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Argentina. Vet Parasitol 1996; 62(3-4): 189–97

    PubMed  CAS  Google Scholar 

  238. Maciel S, Gimenez AM, Gaona C, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Paraguay. Vet Parasitol 1996; 62(3-4): 207–12

    PubMed  CAS  Google Scholar 

  239. Nari A, Salles J, Gil A, et al. The prevalence of anthelmintic resistance in nematode parasites of sheep in southern Latin America: Uruguay. Vet Parasitol 1996; 62(3-4): 213–2

    PubMed  CAS  Google Scholar 

  240. Stelma FF, Talla I, Sow S, et al. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am J Trop Med Hyg 1995; 53(2): 167–70 i]241._Fallon PG, Sturrock RF, Niang AC, et al. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 1995; 53(1): 61–2

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wellcome Trust Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK

    Nilanthi de Silva,  Helen Guyatt & Donald Bundy

Authors
  1. Nilanthi de Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helen Guyatt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donald Bundy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen Guyatt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Silva, N., Guyatt, H. & Bundy, D. Anthelmintics. Drugs 53, 769–788 (1997). https://doi.org/10.2165/00003495-199753050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199753050-00004

Keywords

Search

Navigation